TAKEDA PHARMACEUTIC-SP ADR
TAKNYSE🏆 #264 by market capEarnings Oct 29US Equity
$17.43▼ $0.05 (−0.31%)
Live1h▼ 0.1%
24h▼ 0.3%
7d▲ 4.2%
14d▼ 1.9%
30d▲ 5.7%
1y▲ 19.0%
🏦Market Cap
$55.45B
Mid Cap
📈Revenue Growth (YoY)
+4.3%
Slowing
📊Gross Margin
62.1%
High
💵FCF Margin
15.2%
Healthy
⚖️P/S Ratio
1.9x
Cheap
Otter Score
64
Fair
📊
Analyst Ratings
Price
$17.43
Total
6
Raised
2
Lowered
1
| Institution | Action | Rating | Date |
|---|---|---|---|
TD Cowen | Reiterated | Outperform | 2023-05-16 |
B of A Securities | Upgraded | Neutral → Buy | 2023-03-16 |
Cowen & Co. | Upgraded | Market Perform → Outperform | 2022-07-19 |
Morgan Stanley | Downgraded | Overweight → Equal Weight | 2021-10-07 |
JP Morgan | Reiterated | Overweight | 2020-03-11 |
Jefferies | Reiterated | Buy | 2019-09-24 |
One row per institution, most recent rating